These mechanisms might explain the reasons why the paclitaxel-induced spinal iPLA2 and cPLA2 activation and subsequent LPA production are delayed as compared with the case of peripheral nerve injury. This evidence concerns the gene PLA2G4A and peripheral nerve injury.